Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2023-05-22
4:05 pm
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		Kinnevik AB (publ)10,405,668
5.6%		10,405,668increase
(New Position)		View
2023-02-14
4:05 pm
Sale		13GRecursion Pharmaceuticals, Inc.
RXRX		Lux Capital Management LLC6,004,722
3.3%		-7,016,797decrease
(-53.89%)		View
2023-02-09
11:30 am
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		VANGUARD GROUP INC10,057,363
5.54%		10,057,363increase
(New Position)		View
2023-02-03
12:10 pm
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		BlackRock Inc.
BLK		10,667,624
5.9%		10,667,624increase
(New Position)		View
2023-01-24
07:35 am
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		BAILLIE GIFFORD & CO24,820,850
13.66%		2,697,695increase
(+12.19%)		View
2022-10-31
4:08 pm
Purchase		13DRecursion Pharmaceuticals, Inc.
RXRX		Mubadala Investment Co PJSC11,291,937
6.3%		2,551,020increase
(+29.18%)		View
2022-02-14
4:16 pm
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		Lux Capital Management LLC13,021,519
8.2%		13,021,519increase
(New Position)		View
2022-02-14
3:23 pm
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		Data Collective IV L.P.13,619,224
8.5%		13,619,224increase
(New Position)		View
2022-01-27
10:18 am
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		BAILLIE GIFFORD & CO22,123,155
13.87%		5,104,498increase
(+29.99%)		View
2021-11-04
5:27 pm
Unchanged		13DRecursion Pharmaceuticals, Inc.
RXRX		Mubadala Investment Co PJSC8,740,917
5.5%		0
(Unchanged)		View
2021-05-06
12:01 pm
Purchase		13GRecursion Pharmaceuticals, Inc.
RXRX		BAILLIE GIFFORD & CO17,018,657
10.89%		17,018,657increase
(New Position)		View
2021-04-26
4:34 pm
Purchase		13DRecursion Pharmaceuticals, Inc.
RXRX		Mubadala Investment Co PJSC8,740,917
5.7%		8,740,917increase
(New Position)		View